Stephen Taub Bucking the Trend, Top Hedge Fund Makes Plans for a Second SPAC Life sciences firm Cormorant, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Stephen Taub January 25, 2024